Búsqueda | Portal de Búsqueda de la BVS Ecuador

1.

Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial.

Magro, Fernando; Protic, Marijana; De Hertogh, Gert; Chan, Lai Shan; Pollack, Paul; Jairath, Vipul; Carlier, Hilde; Hon, Emily; Feagan, Brian G; Harpaz, Noam; Pai, Rish; Reinisch, Walter.

Clin Gastroenterol Hepatol ; 2023 Nov 20.

Artículo en Inglés | MEDLINE | ID: mdl-37993033

2.

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn's Disease.

Sands, Bruce E; Peyrin-Biroulet, Laurent; Kierkus, Jaroslaw; Higgins, Peter D R; Fischer, Monika; Jairath, Vipul; Hirai, Fumihito; D'Haens, Geert; Belin, Ruth M; Miller, Debra; Gomez-Valderas, Elisa; Naegeli, April N; Tuttle, Jay L; Pollack, Paul F; Sandborn, William J.

Gastroenterology ; 162(2): 495-508, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-34748774

3.

Effects of Ustekinumab on Histologic Disease Activity in Patients With Crohn's Disease.

Li, Katherine; Friedman, Joshua R; Chan, Daphne; Pollack, Paul; Yang, Feifei; Jacobstein, Douglas; Brodmerkel, Carrie; Gasink, Christopher; Feagan, Brian G; Sandborn, William J; Rutgeerts, Paul; De Hertogh, Gert.

Gastroenterology ; 157(4): 1019-1031.e7, 2019 10.

Artículo en Inglés | MEDLINE | ID: mdl-31279870

4.

Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn's Disease.

Rutgeerts, Paul; Gasink, Christopher; Chan, Daphne; Lang, Yinghua; Pollack, Paul; Colombel, Jean-Frederic; Wolf, Douglas C; Jacobstein, Douglas; Johanns, Jewel; Szapary, Philippe; Adedokun, Omoniyi J; Feagan, Brian G; Sandborn, William J.

Gastroenterology ; 155(4): 1045-1058, 2018 10.

Artículo en Inglés | MEDLINE | ID: mdl-29909019

5.

Increased risk of malignancy with adalimumab combination therapy, compared with monotherapy, for Crohn's disease.

Osterman, Mark T; Sandborn, William J; Colombel, Jean-Frederic; Robinson, Anne M; Lau, Winnie; Huang, Bidan; Pollack, Paul F; Thakkar, Roopal B; Lewis, James D.

Gastroenterology ; 146(4): 941-9, 2014 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-24361468

6.

Adalimumab induces deep remission in patients with Crohn's disease.

Colombel, Jean-Frédéric; Rutgeerts, Paul J; Sandborn, William J; Yang, Mei; Camez, Anne; Pollack, Paul F; Thakkar, Roopal B; Robinson, Anne M; Chen, Naijun; Mulani, Parvez M; Chao, Jingdong.

Clin Gastroenterol Hepatol ; 12(3): 414-22.e5, 2014 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-23856361

7.

Milk protein-based infant formula containing rice starch and low lactose reduces common regurgitation in healthy term infants: a randomized, blinded, and prospective trial.

Lasekan, John B; Linke, Hawley K; Oliver, Jeffery S; Carver, Jane D; Blatter, Mark M; Kuchan, Matthew J; Cramer, Jenna M; Pollack, Paul F.

J Am Coll Nutr ; 33(2): 136-46, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-24724771

8.

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.

Rutgeerts, Paul; Van Assche, Gert; Sandborn, William J; Wolf, Douglas C; Geboes, Karel; Colombel, Jean-Frédéric; Reinisch, Walter; Kumar, Ashish; Lazar, Andreas; Camez, Anne; Lomax, Kathleen G; Pollack, Paul F; D'Haens, Geert.

Gastroenterology ; 142(5): 1102-1111.e2, 2012 May.

Artículo en Inglés | MEDLINE | ID: mdl-22326435

9.

Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial.

Colombel, Jean-Frédéric; Sandborn, William J; Rutgeerts, Paul; Kamm, Michael A; Yu, Andrew P; Wu, Eric Q; Pollack, Paul F; Lomax, Kathleen G; Chao, Jingdong; Mulani, Parvez M.

Am J Gastroenterol ; 104(5): 1170-9, 2009 May.

Artículo en Inglés | MEDLINE | ID: mdl-19352339

10.

Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trial.

Loftus, Edward V; Feagan, Brian G; Colombel, Jean-Frédéric; Rubin, David T; Wu, Eric Q; Yu, Andrew P; Pollack, Paul F; Chao, Jingdong; Mulani, Parvez.

Am J Gastroenterol ; 103(12): 3132-41, 2008 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-18853973

11.

Loss of treatment response to infliximab maintenance therapy in Crohn's disease: a payor perspective.

Wu, Eric Qiong; Mulani, Parvez M; Yu, Andrew Peng; Tang, Jackson; Pollack, Paul F.

Value Health ; 11(5): 820-9, 2008.

Artículo en Inglés | MEDLINE | ID: mdl-18489509

12.

Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.

Sandborn, William J; Rutgeerts, Paul; Enns, Robert; Hanauer, Stephen B; Colombel, Jean-Frédéric; Panaccione, Remo; D'Haens, Geert; Li, Ju; Rosenfeld, Marie R; Kent, Jeffrey D; Pollack, Paul F.

Ann Intern Med ; 146(12): 829-38, 2007 Jun 19.

Artículo en Inglés | MEDLINE | ID: mdl-17470824

13.

When meta-analysis misleads.

Yang, Mei; Robinson, Anne M; Pollack, Paul F.

Am J Gastroenterol ; 106(11): 2043; author reply 2044, 2011 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-22056581

14.

Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.

Whitcomb, David C; Bodhani, Amit; Beckmann, Katrin; Sander-Struckmeier, Suntje; Liu, Shufang; Fuldeore, Mahesh; Pollack, Paul F; Khurmi, Rupal P.

Pancreas ; 45(5): 679-86, 2016.

Artículo en Inglés | MEDLINE | ID: mdl-26495784

15.

Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children.

Al-Alaiyan, Saleh; Pollack, Paul; Notario, Gerard F.

Drugs Context ; 42015.

Artículo en Inglés | MEDLINE | ID: mdl-25767550

16.

Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection.

Lacaze-Masmonteil, Thierry; Seidenberg, Juergen; Mitchell, Ian; Cossey, Veerle; Cihar, Martin; Csader, Michal; Baarsma, Rienk; Valido, Marques; Pollack, Paul F; Groothuis, Jessie R.

Drug Saf ; 26(4): 283-91, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-12608889

17.

Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency.

Sander-Struckmeier, Suntje; Beckmann, Katrin; Janssen-van Solingen, Gwendolyn; Pollack, Paul.

Pancreas ; 42(6): 983-9, 2013 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-23587850

18.

Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial.

Louis, Edouard; Löfberg, Robert; Reinisch, Walter; Camez, Anne; Yang, Mei; Pollack, Paul F; Chen, Naijun; Chao, Jingdong; Mulani, Parvez M.

J Crohns Colitis ; 7(1): 34-43, 2013 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-22480772

19.

52-week efficacy of adalimumab in patients with moderately to severely active ulcerative colitis who failed corticosteroids and/or immunosuppressants.

Reinisch, Walter; Sandborn, William J; Panaccione, Remo; Huang, Bidan; Pollack, Paul F; Lazar, Andreas; Thakkar, Roopal B.

Inflamm Bowel Dis ; 19(8): 1700-9, 2013 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-23665965

20.

Serum adalimumab concentration and clinical remission in patients with Crohn's disease.

Chiu, Yi-Lin; Rubin, David T; Vermeire, Severine; Louis, Edouard; Robinson, Anne M; Lomax, Kathleen G; Pollack, Paul F; Paulson, Susan K.

Inflamm Bowel Dis ; 19(6): 1112-22, 2013 May.

Artículo en Inglés | MEDLINE | ID: mdl-23584130

Portal de Búsqueda de la BVS Ecuador

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: